No 9 (2019)

Full Issue

PDF(Russian)
Articles
Minzdrav predlozhit poryadok organizatsii reabilitatsii vzroslykh patsientov
Article E.
Abstract
Минздрав РФ разработал порядок организации медицинской реабилитации для взрослых пациентов, документ опубликован для общественного обсуждения на портале нормативных правовых актов. С 2012 г. реабилитация детей и взрослых в России регулировалась единым приказом Минздрава, однако, поскольку медицинская помощь каждой возрастной группе имеет свои особенности, было принято решение разработать для них отдельные порядки реабилитации. Документ, регулирующий реабилитацию детей, был опубликован министерством ранее. «Взрослый» порядок реабилитации предусматривает участие в медицинской помощи представителей ряда новых медицинских специальностей, таких как врач физической и реабилитационной медицины, кинезитерапевт, эрготерапевт, клинический логопед, медицинский психолог. Кроме того, документ детализирует подходы к маршрутизации пациентов в зависимости от тяжести состояния, этапа оказываемой реабилитации, уровня медицинской организации, которая ведет пациента. Предполагается, что новый порядок вступит в силу 1 января 2021 г.
REMEDIUM. 2019;(9):4-5
views
Development of the rare (orphan) drug market
Yurochkin D.S., Golant Z.M., Narkevich I.A.
Abstract
As a result of the dynamic economic analysis of the rare (orphan) drug market evolution, the authors proposed comprehensive solutions that contribute to the satisfaction of needs of the national health service, which are based on a systematic approach to the regulation and development of local production:s a result of the dynamic economic analysis of the rare (orphan) drug market evolution, the authors proposed comprehensive solutions that contribute to the satisfaction of needs of the national health service, which are based on a systematic approach to the regulation and development of local production: • identify a separate segment of orphan drugs in the drug supply system for reasons of the specific features of registration, pricing and market authorization of such drugs; • recommend the development of individual regulatory documents, including improvement of the drug provision procedure, taking into account integration into the existing drug circulation system; • create a subprogram for the development and organization of the production of rare (orphan) drugs at the level of a specialized state program for the development of the pharmaceutical industry of the Russian Federation.
REMEDIUM. 2019;(9):6-12
views
Dementia drugs market analysis in Russia
Trofimova Е.О., Izvekov N.V.
Abstract
The paper deals with the analysis results of the Russian market of drugs used in basic therapy for Alzheimer's disease and other forms of dementia, which are prescribed to slow down the degradation of cognitive ability. IQVIA databases were used as the primary source of data on sales. The analysis showed that the main part of the drugs used was paid by the population using their own funds (80% in value terms at the end of 2018), which sets a limit on the availability of background therapy for patients with dementia. Retail sales in 2017-2018 demonstrated high growth rates (at the level of 16-17% per year), while government procurements were subject to significant fluctuations. The total consumption of background therapy drugs in Russia was 41.7 mil. DDD to the amount of 2.6 bil. rubles at wholesale prices in 2018.
REMEDIUM. 2019;(9):16-25
views
On the verge of an epidemic season
Prozherina J.
Abstract
The seasonality and course severity of influenza and acute respiratory viral infections (ARVI) have undergone significant changes in recent years. For example, there was no marked increase in the incidence rates over a period of 2018/19 that were traditionally observed in the winter period, which also had an impact on the pharmacy sales of combined anti-cold drugs as one of the most widely used drug groups in the cold season. At the same time, an increasing incidence of colds coincides with not so typical periods, especially at the beginning of autumn.
REMEDIUM. 2019;(9):26-28
views
Sovremennye tekhnologii izmenyayut prognoz bol'nykh s insul'tom. Interv'yu s Mikhailom Piradovym
Article E.
Abstract
Инсульт - одно из самых тяжелых и опасных состояний, которое часто заканчивается смертью или инвалидностью. О новых возможностях современной медицины в борьбе с неврологическими заболеваниями, прежде всего инсультом и его последствиями, мы решили поговорить с Михаилом ПИРАДОВЫМ, директором ФГБНУ «Научный центр неврологии», академиком РАН, профессором, д.м.н.
REMEDIUM. 2019;(9):29-31
views
Understanding stroke through the lens of global trends
Prozherina Y., Shirokova I.
Abstract
A lot of new data that have led to significant changes in approaches to the therapy for ischemic stroke have accumulated globally in recent years. A significant part of these changes is provided in the new guidelines for the early management of patients with acute ischemic stroke from the American Heart Association/ American Stroke Association, published in the Stroke journal in the spring of 2018 [1, 2]. These changes have been adopted by the domestic healthcare system.
REMEDIUM. 2019;(9):32-34
views
«Kompleksnye preparaty zanimayut dostoynoe mesto v lechenii zaporov». Interv'yu s Valeriem Makhovym
Article E.
Abstract
Запор не только одно из наиболее распространенных расстройств, встречающихся у современного человека, но и зачастую серьезная медицинская проблема. Качество жизни людей, страдающих хроническим запором, сравнимо с таковым у больных сахарным диабетом, артериальной гипертензией и депрессией. Какова природа запора и какие меры позволяют пациенту нормализовать стул - мы решили узнать у Валерия МАХОВА, научного руководителя гастроэнтерологического отделения Клиники факультетской терапии имени В. Н. Виноградова Первого МГМУ им. И. М. Сеченова, профессора кафедры факультетской терапии № 1 лечебного факультета Первого МГМУ имени И. М. Сеченова, д.м.н.
REMEDIUM. 2019;(9):36-38
views
Innovative technologies become available for psoriasis patients
Prozherina Y., Shirokova I.
Abstract
Searching for therapeutic opportunities that can significantly improve the patient's condition and prognosis of the disease is a key goal in the treatment of psoriasis, which holds a special place among all serious chronic diseases. The creation of the first Russian original monoclonal antibody to treat the disease is a vital step forward in this direction.
REMEDIUM. 2019;(9):40-44
views
Combination of private and public interests in the legal regulation of gene technologies
Mokhov А.А., Yavorskiy A.N.
Abstract
The development of genetic technologies, the implementation of a biomedical project in the country, the transition of public health service to the principles of 4 Ps - such are modern trends. Consequently, the question of the day is the formation of legislation regulating the scientific, innovative, medical and other areas, where gene technologies can be actively used. This requires the development of the foundations and principles of their legal regulation, including the principle for combining private and public interests. In the future, legislation regulating gene technologies will be formed based on the definition of the pool of participants in this process, their interests that are necessary for this area of permissions, obligations and prohibitions.
REMEDIUM. 2019;(9):48-51
views
Monthly review: production, investment, finance
Romanova S.
Abstract
Performance analysis of industry enterprises is conducted using the national statistics reports: Form P-1 urgent (monthly), Form No. P-2 «Information on Investments in Non-Financial Assets» (quarterly), Form No. P-3 «Information on Company Financial Status» (monthly).
REMEDIUM. 2019;(9):54-68
views
Monthly review: business activity of industry enterprises
Romanova S.
Abstract
The rating was prepared using the state accounting data of 90 leading pharmaceutical manufacturers.
REMEDIUM. 2019;(9):69-72
views
Quarterly judicial review pertaining to the production and circulation of medical products for May - July 2019
Borzova M.
Abstract
The monthly review provides an analysis of court practice pertaining to the production and circulation of medical products to help industry specialists avoid mistakes in solving similar problems.
REMEDIUM. 2019;(9):73-76
views
Lechenie raka - starye problemy i novye vozmozhnosti
Article E.
Abstract
Широкий круг актуальных вопросов, связанных с оказанием медицинской помощи больным раком, обсудили участники круглого стола, состоявшегося в конце мая в Общественной палате РФ. Специалисты акцентировали внимание на проблеме доступности лечения, в т. ч. инновационного, и новых возможностях, появившихся у онкологических пациентов в рамках реализации федерального проекта «Борьба с онкологическими заболеваниями», который стартовал в этом году.
REMEDIUM. 2019;(9):80-81
views
TOP-pozitsii. Pokazateli vedushchikh mirovykh i otechestvennykh proizvoditeley i distrib'yuterov
Article E.
Abstract
Производство медицинской продукции за август Производство медицинской продукции за август Импорт ГЛС в Россию по итогам II квартала 2019 года Экспорт ГЛС из России по итогам II квартала 2019 года Фармацевтическая реклама ЛП и БАД в российских СМИ в июне 2019 года
REMEDIUM. 2019;(9):82-88
views

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
National research Institute of public health named after N. A. Semashko

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies